We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$5.65B
AUM Growth
+$471M
(+9.1%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
1,507
New
476
Increased
192
Reduced
202
Closed
448
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$14.4M |
| 2 |
argenx
ARGX
|
+$13.4M |
| 3 |
Compañía de Minas Buenaventura
BVN
|
+$13.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$11.3M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$16.7M |
| 2 |
Sabre
SABR
|
+$12.5M |
| 3 |
UBS Group
UBS
|
+$10.2M |
| 4 |
Walt Disney
DIS
|
+$9.97M |
| 5 |
CBL
CBL Properties
CBL
|
+$7.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.56% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Communication Services | 0.87% |
| 5 | Industrials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
CALL
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $845K | 0.02% |
60,000
-5,000
| -8% | -$66.9K |
|
|
702
PUT
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $845K | 0.02% |
60,000
-5,000
| -8% | -$66.9K |
|
703
CGI
GIB
$15.1B
| $843K | 0.01% |
+8,000
| New | +$815K |
|
|
MPT
704
Medical Properties Trust
MPT
$2.77B
| $833K | 0.01% |
90,000
-91,700
| -50% | -$776K |
|
705
Blue Owl Capital
OWL
$6.96B
| $828K | 0.01% |
71,035
+50,207
| +241% | +$540K |
|
706
FerroAtlántica
GSM
$594M
| $824K | 0.01% |
+172,800
| New | +$795K |
|
707
Peabody Energy
BTU
$2.6B
| $821K | 0.01% |
37,900
-18,200
| -32% | -$403K |
|
|
NEWR
708
PUT
DELISTED
New Relic, Inc.
NEWR
| $818K | 0.01% |
+12,500
| New | +$901K |
|
709
Viant Technology
DSP
$236M
| $817K | 0.01% |
177,287
-24,814
| -12% | -$110K |
|
|
GLDD
710
CALL
DELISTED
Great Lakes Dredge & Dock
GLDD
| $816K | 0.01% |
+100,000
| New | +$649K |
|
711
PUT
Arcutis Biotherapeutics
ARQT
$3.36B
| $810K | 0.01% |
+85,000
| New | +$943K |
|
712
SiriusXM
SIRI
$9.98B
| $807K | 0.01% |
17,825
-29,675
| -62% | -$1.12M |
|
|
CPRX
713
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
| $806K | 0.01% |
60,000
| – | – |
|
714
Murphy Oil
MUR
$5.7B
| $804K | 0.01% |
+21,000
| New | +$775K |
|
715
PUT
StepStone Group
STEP
$3.61B
| $801K | 0.01% |
+32,300
| New | +$742K |
|
716
Amylyx Pharmaceuticals
AMLX
$2.26B
| $798K | 0.01% |
+37,000
| New | +$999K |
|
717
PUT
SL Green Realty
SLG
$3.76B
| $796K | 0.01% |
26,500
-817,100
| -97% | -$19.7M |
|
718
Allot
ALLT
$372M
| $794K | 0.01% |
251,151
-20,780
| -8% | -$58.5K |
|
719
CALL
Fastly Inc
FSLY
$3.55B
| $789K | 0.01% |
50,000
-283,300
| -85% | -$4.34M |
|
720
AGNC Investment
AGNC
$12.4B
| $788K | 0.01% |
77,800
+40,100
| +106% | +$390K |
|
|
PYCR
721
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $785K | 0.01% |
+33,150
| New | +$773K |
|
722
Newell Brands
NWL
$2.38B
| $783K | 0.01% |
+90,000
| New | +$895K |
|
723
PUT
Viking Therapeutics
VKTX
$3.7B
| $781K | 0.01% |
+48,200
| New | +$1.01M |
|
|
TSP
724
CALL
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $779K | 0.01% |
469,500
| – | – |
|
|
FL
725
DELISTED
Foot Locker
FL
| $777K | 0.01% |
+28,644
| New | +$975K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2023 Portfolio in Review
As of Q2 2023, Caption Management held 1,507 positions worth $5.65B, up 9.1% from $5.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management deployed $283M of net new capital in Q2 2023, opening 476 new positions and adding to 192 existing holdings. Its largest new stake was Lockheed Martin: 31,000 shares worth $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 2% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Sabre, an estimated $12.5M trimmed.
- Caption Management's largest Q2 2023 buy was Lockheed Martin: 31,000 shares worth $14.3M.
- Caption Management added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $11M increase.
- Caption Management's biggest Q2 2023 reduction was Sabre, cutting an estimated $12.5M.
- Caption Management fully exited KraneShares CSI China Internet ETF in Q2 2023, selling an estimated $16.7M.
- Caption Management's ten largest holdings make up 18% of its $5.65B portfolio in Q2 2023.
- Caption Management opened 476 new positions and closed 448 in Q2 2023.
- Caption Management's portfolio value rose 9.1% quarter-over-quarter to $5.65B.
Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.